XOMA Corp. | Key People and Executives
James R. Neal
Chief Executive Officer & Director
W. Denman van Ness
Chairman
Matthew D. Perry
Independent Director
Joseph M. Limber
Independent Director
Jack L. Wyszomierski
Independent Director
James R. Neal
Chief Executive Officer & Director
Thomas Burns
Chief Financial Officer & Senior VP-Finance
Dee Datta
Chief Business Officer
Danny J. Hart
Vice President & General Counsel
W. Denman van Ness
Chairman
Matthew D. Perry
Independent Director
Joseph M. Limber
Independent Director
Jack L. Wyszomierski
Independent Director
| Address |
2200 Powell Street
Emeryville California 94608
United States
|
|
Employees
|
- |
| Website |
http://www.xoma.com |
| Updated |
07/08/2019 |
| XOMA Corp. engages in the discovery and development of innovative therapeutics derived from unique platform of antibody technologies. Its products includes X358, X213, X129, and gevokizumab. The company was founded by Patrick J. |
